Frank van Leth's Avatar

Frank van Leth

@fvlscience.bsky.social

Epidemiologist. Intersection methodology, infectious diseases and social science. Vrije Universiteit Amsterdam. Dept. Healh Sciences, Head section International Health. Vice-director Amsterdam Public Health research institute. #TB #HIV #AMR #syndemics

2,607 Followers  |  1,349 Following  |  86 Posts  |  Joined: 25.01.2024  |  2.2903

Latest posts by fvlscience.bsky.social on Bluesky

πŸ“Œ

20.07.2025 13:24 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Looking for the same at this very momeny

27.06.2025 11:47 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

Great work

06.06.2025 08:14 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
View of conference hall with announcement screen: jpiamr final conference 2025

View of conference hall with announcement screen: jpiamr final conference 2025

View of conference hall with announcement screen: jpiamr final conference 2025

View of conference hall with announcement screen: jpiamr final conference 2025

With the #jpiamr program closing, there is a final conference on its achievements. Nice gathering of funders, scientists of all walks, and policy makers. Lessons learned when moving to EU partnership OneHealth. Looking forward to new era.

08.05.2025 08:46 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

So relatable. Makes me desperate every now and then.

25.04.2025 17:21 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

I posted the same thoughts. But I think the BYE part of each of the licences is violated as you are not acknowledged. Copilot gives 2 or so references if you use an account. Unlikely it will be your paper.

21.03.2025 12:12 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

I think the BY clause in licence is in the end violated. Although proper reference might shown in in copilot (with account)

21.03.2025 05:19 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

I have 30+ articles in database. Most of them OA published with standard journal CC-BY licence. Is Meta than allowed? Should I insist journals to use CC-BY-NC to avoid commercial use?

20.03.2025 19:14 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 2    πŸ“Œ 0

Great post. As always. Thanks

20.03.2025 17:51 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

πŸ“Œ

12.03.2025 06:18 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Large crowd filling the streets around parlement square in cetral Athens. Picture taken from computer screen

Large crowd filling the streets around parlement square in cetral Athens. Picture taken from computer screen

Gathering of people in Museum square in Amsterdam. Some playcard signs in the background

Gathering of people in Museum square in Amsterdam. Some playcard signs in the background

Crowds are different. The anger is the same. Tembi 2 years after the train crash. #τΡμπι.

28.02.2025 18:54 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

The Dutch gvt joins the move to shortsightedness. "Development aid only for projects with direct returns for the Netherlands". Exit sexual health, women partcipation, and climate.
#development #aid #RSH. A sad day for many

20.02.2025 19:09 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

What an ibsightful thread! Thanks and congrats on the results

13.02.2025 16:26 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

The WHO research agenda for #AMR in human health has identified 40 research priorities to be addressed by 2030, focusing on bacterial and fungal pathogens critical for AMR. Target is to encourage evidence generation for effective AMR policy translation
www.sciencedirect.com/science/arti...

04.02.2025 09:02 β€” πŸ‘ 38    πŸ” 16    πŸ’¬ 0    πŸ“Œ 1

Congrsts. Great and important work

30.01.2025 14:22 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Welcome. Good to know

20.01.2025 11:01 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

We share a lot of our ideas, code, datasets (that we spend years sanitizing) early. Often way before we release preprints. We do this so that others can use, build on, improve & even "beat" our approaches. But I want to say a few things about some simple expectations 1/

17.01.2025 17:16 β€” πŸ‘ 90    πŸ” 25    πŸ’¬ 1    πŸ“Œ 5
Preview
In memory of Armand Van Deun To honour Armand Van Deun's legacy in TB research & treatment, we launched the Armand Van Deun Scholarship Initiative, a cause you can also support

The Institute of Tropical Medicine in Antwerp launched the Armand Van Deun Scholarship Initiative in honour of his legacy. Armand was founding father of our short course Clinical Decision-Making for Drug-Resistant Tuberculosis (DR-TB) @ITM. Read more: www.itg.be/en/health-st...

13.01.2025 15:43 β€” πŸ‘ 3    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0

Great topic. Congrats

08.01.2025 20:52 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Illustrating the structures of bias from immortal time using directed acyclic graphs AbstractBackground. Immortal time is a period of follow-up during which death or the study outcome cannot occur by design. Bias from immortal time has been

Our work on immortal time bias "Illustrating the structures of bias from immortal time using directed acyclic graphs" led by Emma Guoyi Yang @yanggy_hku is out at International Journal of Epidemiology: doi.org/10.1093/ije/.... Brief thread:

08.01.2025 08:50 β€” πŸ‘ 56    πŸ” 25    πŸ’¬ 5    πŸ“Œ 1
Preview
Transmission as a Key Driver of Resistance to the New Tuberculosis Drugs | NEJM Whole-genome sequencing was used to show that resistance to newer antituberculosis drugs is present in at least 27 countries and that up to a quarter of this resistance may be due to person-to-...

⚠️ Bit of an alarm bell to MDR-TB regimen BPaL/M - resistance to constituent antibiotics developing and transmission of such strains already occurring
#TBSky #IDSky @nejm.org

www.nejm.org/doi/10.1056/...

05.01.2025 07:57 β€” πŸ‘ 39    πŸ” 18    πŸ’¬ 6    πŸ“Œ 2

πŸ“Œ

01.01.2025 11:00 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

πŸ“Œ

21.12.2024 07:34 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Giant study finds untrustworthy trials pollute gold-standard medical reviews Two-year collaboration aims to create tools to help counter the tide of flawed research.

Fake or flawed studies are polluting systematic reviews in medicine and other fields - but how do you spot them?
For Nature, I report on efforts to create a short checklist of red flags, and on the automated integrity tools emerging to help.
www.nature.com/articles/d41...

18.12.2024 12:14 β€” πŸ‘ 74    πŸ” 28    πŸ’¬ 3    πŸ“Œ 3
β€˜Poora saal waste ho jayega’: Delhi teen struggles with drug-resistant TB as key medicines out of stock MDR TB is caused by germs that are resistant to two or more of the main tuberculosis drugs -- isoniazid and rifampin.

indianexpress.com/article/citi...

Access to drugs continues to be a major concern for TB control. All the science in the world can't help if we can't get the drugs. #TBSky #endTB HT Ankita Upadhyay on twitter.

18.12.2024 02:42 β€” πŸ‘ 13    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0

Congratulations

18.12.2024 06:10 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

πŸ“Œ

09.12.2024 07:30 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

πŸ“Œ

06.12.2024 19:58 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Rather happy with this one. We used a Lot Quality Assurance Sampling (LQAS) approach in surveillance of #AMR in #UTI in Indonesia. Working on this rapid surveillance approach for quite a while.
doi.org/10.1093/aje/...

05.12.2024 11:50 β€” πŸ‘ 7    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Preview
Impact of a hub-and-spoke approach to hospital antimicrobial stewardship programmes on antibiotic use in Zambia AbstractBackground. Antimicrobial stewardship programmes (ASPs) aim to optimize antibiotic use and prevent antimicrobial resistance.Objective. This study a

A hub-and-spoke approach to implementing #AntimicrobialStewardship programmes (ASPs) in Zambian hospitals improved the core elements of #AMS practice and modestly reduced antibiotic use over 1 year, offering insights for strengthening ASPs in Africa: https://buff.ly/4ghXvDP
#JACAMRNews

05.12.2024 11:00 β€” πŸ‘ 1    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0

@fvlscience is following 20 prominent accounts